{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:55:24Z","timestamp":1794027324723,"version":"4.8.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>ANCA-associated vasculitis (AAV) includes granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. Epidemiological studies in AAV are important in understanding possible aetiologic mechanisms and facilitating healthcare planning. However, epidemiological studies present a number of challenges including clear definition of cases differentiated from other clinical disorders, and identification of cases due to the rarity of AAV. The aim of this review is to summarize different aspects on the epidemiology of ANCA-associated vasculitis from different geographical areas throughout the world. During the past three decades, development of classification criteria worldwide, including the ACR classification of 1990, the Chapel Hill consensus definitions updated in 2012 and the EMA algorithm has facilitated epidemiology studies in AAV. The available epidemiological studies reported in AAV suggest that incidence and prevalence may have increased over the past 30\u2009years. Possible explanations for this increase may be a genuine increase in incidence, the evolution of classification criteria and the definition, and availability and wider use of ANCA serology to aid diagnosis, and greater physician awareness through education. The age-specific incidence for the whole group of AAV showed a clear increase with age. However, there has been a clear shift in the peak age at onset towards a higher age during the last 20\u201330\u2009years. In addition, variation in incidence of AAV between men and women has been clearly evident in a number of epidemiological studies.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa089","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T20:11:01Z","timestamp":1581624661000},"page":"iii42-iii50","source":"Crossref","is-referenced-by-count":136,"title":["An update on the epidemiology of ANCA-associated vasculitis"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-6936","authenticated-orcid":false,"given":"Aladdin J","family":"Mohammad","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund, Sweden"},{"name":"Department of Medicine, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"2020042913160950300_keaa089-B1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction","volume":"33","author":"Hunder","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary","volume":"33","author":"Fries","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-129-5-199809010-00013","article-title":"The use and misuse of classification and diagnostic criteria for complex diseases","volume":"129","author":"Hunder","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020042913160950300_keaa089-B4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-129-5-199809010-00001","article-title":"Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis","volume":"129","author":"Rao","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020042913160950300_keaa089-B5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B6","first-page":"3","article-title":"Microscopic polyangiitis (microscopic polyarteritis)","volume":"18","author":"Jennette","year":"2001","journal-title":"Semin Diagn Pathol"},{"key":"2020042913160950300_keaa089-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2020042913160950300_keaa089-B9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","article-title":"Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden","volume":"46","author":"Mohammad","year":"2007","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B12","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/rheumatology\/ken079","article-title":"Evaluation of a new algorithm in classification of systemic vasculitis","volume":"47","author":"Liu","year":"2008","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10157-013-0854-0","article-title":"ACR\/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)","volume":"17","author":"Craven","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2020042913160950300_keaa089-B15","first-page":"284","article-title":"Systemic vasculitis in the 1980s\u2013is there an increasing incidence of Wegener\u2019s granulomatosis and microscopic polyarteritis?","volume":"24","author":"Andrews","year":"1990","journal-title":"J R Coll Physicians Lond"},{"key":"2020042913160950300_keaa089-B16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.11115","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions","volume":"49","author":"Gonzalez-Gay","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2020042913160950300_keaa089-B18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","article-title":"Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom","volume":"43","author":"Watts","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1445-5994.2008.01672.x","article-title":"Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales","volume":"38","author":"Ormerod","year":"2008","journal-title":"Intern Med J"},{"key":"2020042913160950300_keaa089-B20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","article-title":"Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects","volume":"78","author":"Gonzalez-Gay","year":"1999","journal-title":"Medicine"},{"key":"2020042913160950300_keaa089-B21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/rheumatology\/41.5.540","article-title":"No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register","volume":"41","author":"Reinhold-Keller","year":"2002","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/35.2.142","article-title":"Wegener\u2019s granulomatosis\u2013increased incidence or increased recognition?","volume":"35","author":"Carruthers","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2020042913160950300_keaa089-B24","first-page":"2060","article-title":"Increasing incidence of Wegener\u2019s granulomatosis in Sweden, 1975-2001","volume":"33","author":"Knight","year":"2006","journal-title":"J Rheumatol"},{"key":"2020042913160950300_keaa089-B25","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6","article-title":"Epidemiology of Wegener\u2019s granulomatosis in northern Norway","volume":"43","author":"Koldingsnes","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B26","first-page":"S81","article-title":"Incidence of Wegener\u2019s granulomatosis in Finland 1981-2000","volume":"26","author":"Takala","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2020042913160950300_keaa089-B27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10067-016-3232-y","article-title":"The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey","volume":"35","author":"Pamuk","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2020042913160950300_keaa089-B28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020042913160950300_keaa089-B29","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.40577","article-title":"Epidemiology and outcomes of granulomatosis with polyangiitis in pediatric and working-age adult populations in the United States: analysis of a large national claims database","volume":"70","author":"Panupattanapong","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020042913160950300_keaa089-B30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s10067-019-04463-y","article-title":"Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study","volume":"38","author":"Pierini","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2020042913160950300_keaa089-B31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1445-5994.2008.01694.x","article-title":"Wegener\u2019s granulomatosis: epidemiological and clinical features in a South Australian study","volume":"38","author":"Hissaria","year":"2008","journal-title":"Intern Med J"},{"key":"2020042913160950300_keaa089-B32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1445-5994.2006.01297.x","article-title":"Wegener\u2019s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient","volume":"37","author":"O\u2019Donnell","year":"2007","journal-title":"Intern Med J"},{"key":"2020042913160950300_keaa089-B33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/39.12.1396","article-title":"Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany","volume":"39","author":"Reinhold-Keller","year":"2000","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","article-title":"Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany","volume":"53","author":"Herlyn","year":"2014","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01450893","article-title":"Primary vasculitis in a Norwegian community hospital: a retrospective study","volume":"17","author":"Haugeberg","year":"1998","journal-title":"Clin Rheumatol"},{"key":"2020042913160950300_keaa089-B37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780390112","article-title":"The epidemiology of Wegener\u2019s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources","volume":"39","author":"Cotch","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2020042913160950300_keaa089-B38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/rheumatology\/kei259","article-title":"The epidemiology of Wegener\u2019s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region","volume":"45","author":"Gibson","year":"2006","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0889-857X(21)00479-8","article-title":"Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment","volume":"21","author":"Lhote","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"2020042913160950300_keaa089-B40","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2215\/CJN.01461005","article-title":"Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan","volume":"1","author":"Fujimoto","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020042913160950300_keaa089-B41","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","article-title":"Renal vasculitis in Japan and the UK\u2013are there differences in epidemiology and clinical phenotype?","volume":"23","author":"Watts","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2020042913160950300_keaa089-B42","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology"},{"key":"2020042913160950300_keaa089-B43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3899\/jrheum.131038","article-title":"A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis","volume":"41","author":"Mohammad","year":"2014","journal-title":"J Rheumatol"},{"key":"2020042913160950300_keaa089-B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","article-title":"Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies","volume":"244","author":"Franssen","year":"1998","journal-title":"J Intern Med"},{"key":"2020042913160950300_keaa089-B45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3899\/jrheum.150557","article-title":"The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study","volume":"43","author":"Nesher","year":"2016","journal-title":"J Rheumatol"},{"key":"2020042913160950300_keaa089-B46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020042913160950300_keaa089-B47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/03009740802238366","article-title":"Wegener\u2019s granulomatosis in Finland in 1981-2000: clinical presentation and diagnostic delay","volume":"37","author":"Takala","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"2020042913160950300_keaa089-B48","first-page":"i104","article-title":"Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant","volume":"30","author":"Sacri","year":"2015"},{"key":"2020042913160950300_keaa089-B49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3899\/jrheum.090688","article-title":"Incidence of Wegener\u2019s granulomatosis in children","volume":"37","author":"Grisaru","year":"2010","journal-title":"J Rheumatol"},{"key":"2020042913160950300_keaa089-B50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009742.2017.1412497","article-title":"Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden","volume":"47","author":"Mossberg","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2020042913160950300_keaa089-B51","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/art.24544","article-title":"Prevalence and incidence of Wegener\u2019s granulomatosis in the UK general practice research database","volume":"61","author":"Watts","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/Supplement_3\/iii42\/33145887\/keaa089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/Supplement_3\/iii42\/33145887\/keaa089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T13:51:58Z","timestamp":1665841918000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/Supplement_3\/iii42\/5826908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":51,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2020,4,29]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa089","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,4,29]]}}}